NATtrol S. aureus (MRSA) Stock* is formulated with purified, intact bacterial cells that have been chemically modified to render them non-infectious and refrigerator stable. Each vial contains 1.0 mL of NATtrol? S. aureus (MRSA) stock in a proprietary matrix at the target concentration listed in Table 1 (IFU).

NATtrol S. aureus (MRSA) stock is designed to evaluate the performance of nucleic acid tests for determination of the presence of S. aureus (MRSA) nucleic acid. NATtrol S. aureus (MRSA) stock enables laboratories to monitor test variation, lot-to-lot test kit performance, operator variation, and can provide assistance in identifying random or systemic error.

+2? to +8? C.
Product Insert.pdf

Material Safety Data Sheet.pdf